节点文献

雷帕霉素抑制人肝癌细胞HepG-2侵袭能力的实验研究

Studies of antitumor effect of rapamycin on human hepatocellular carcinoma HepG-2 cells in vitro.

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 李艳雯黎宇姜孝新

【Author】 LI Yan-wen,LI Yu,JIANG Xiao-Xin.Inspection Department of the First Hospital Affiliated to Nanhua University,Hengyan,421001,Hunan,CHINA

【机构】 南华大学附属第一医院检验科南华大学附属第一医院骨科

【摘要】 目的观察雷帕霉素(Rapamycin)体外对肝癌HepG-2细胞侵袭能力的影响。方法用不同浓度的雷帕霉素作用于体外培养的HepG-2细胞,应用Matrigel胶模拟基质检测细胞侵袭能力。结果雷帕霉素能显著降低肿瘤细胞的侵袭能力,随剂量增高降低越明显。各药物处理组与阴性对照组相比差异具有统计学意义(P<0.05)。结论雷帕霉素能有效地降低肝癌细胞HepG-2的侵袭能力。

【Abstract】 Objective To investigate the effect of cell invasion ability induced by rapamycin on human hepatocellular carcinoma HepG-2 cells.Methods HepG-2 cells in vitro were given different concentrations of rapamycin,and the invasion ability of HepG-2 cells was observed by Matrigel.Results Rapamycin could inhibit the invasion ability of HepG-2 cells,and and the inhibit presented dose-dependent relationship.There was significantly different between rapamycin given groups and control group.Conclusion Rapamycin significantly inhibits the invasion ability of HepG-2 cells.

【关键词】 雷帕霉素增殖侵袭
【Key words】 RapamycinProliferationInvasion
  • 【文献出处】 海南医学 ,Hainan Medical Journal , 编辑部邮箱 ,2011年11期
  • 【分类号】R735.7
  • 【被引频次】2
  • 【下载频次】97
节点文献中: 

本文链接的文献网络图示:

本文的引文网络